Practice question

Hypermorph denotes gain-of-function where normal biochemical activity increases in amount or intensity beyond wild-type. Mechanisms include promoter mutations causing overexpression, gene duplication increasing dosage, or missense alteration rendering enzyme constitutively active independent of regulation. Unlike neomorph acquiring novel function, hypermorph amplifies endogenous function leading to dominant or semi-dominant phenotypes with exaggerated signaling. Oncogenic variants such as hyperactive RAS or EGFR exemplify hypermorphic effects driving unrestrained proliferation, illustrating therapeutic relevance of dosage-sensitive gain-of-function classification. This principle illustrates essential molecular mechanisms governing replication fidelity and mutation fixation relevant for exam interpretation.